Radiation after thyroid surgery may keep cancer at bay
NCT ID NCT06524167
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether giving radiation therapy within 6 weeks after surgery can help prevent thyroid cancer from coming back in people at high risk. It includes 80 patients with various types of thyroid cancer (except undifferentiated). The main goal is to see how long they stay free of local or regional recurrence. Researchers will also track overall survival, side effects, and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- radiation therapy (external beam radiotherapy using IMRT or VMAT)
- What this could lead to
- If successful, this could show that adding radiotherapy after surgery improves local control and reduces recurrence in high-risk thyroid cancer patients.
- What could go wrong
- This is a small, real-world study (80 people) without a comparison group, so results may not be definitive. Radiotherapy can cause side effects like fatigue or skin irritation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2024
- Expected to finish
-
Jun 2031
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with high recurrence risk locally advanced thyroid cancer
- Ages
-
14 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients voluntarily join this study and sign an informed consent form; * Age: ≥ 14 years old,\<80 years old, male or female not limited; * Thyroid cancer diagnosed by histopathology, including differentiated thyroid cancer, medullary carcinoma, poorly differentiated carcinoma, etc; * High risk of local late recurrence, meeting any of the following criteria: 1. The surgery did not achieve R0 resection; 2. After neoadjuvant therapy; 3. Pathological types with poor prognosis, such as poorly differentiated cancer, CASTLE, etc; 4. Thyroid cancer with obvious extracapsular invasion, invading important structures such as the esophagus, trachea, and recurrent laryngeal nerve, requiring adjuvant radiotherapy; 5. For patients with distant metastasis, researchers need to determine the value of local treatment; * The main organ functions are normal; * Good compliance and cooperation with follow-up. Exclusion Criteria: * Untreated thyroid cancer or thyroid cancer that has only undergone surgical biopsy; * Within 5 years or simultaneously suffering from other active malignant tumors. Cured local tumors, such as skin basal cell carcinoma, skin squamous cell carcinoma, superficial bladder cancer, prostate carcinoma in situ, cervical carcinoma in situ, breast carcinoma in situ, can be included in the group; * Previously received radiation therapy for the head and neck area; * Pregnant or lactating women; * There are other physical illnesses that affect patients' ability to receive standard treatment; * According to the researcher's judgment, there may be other factors that could force the subject to terminate the study midway, such as suffering from other serious illnesses (including mental illnesses) that require concurrent treatment, severe abnormal laboratory test values, family or social factors that may affect the subject's safety or the collection of trial data; * Individuals with claustrophobia who are unable to undergo radiation therapy; * Other patients deemed unsuitable for inclusion by the treating physician.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Thyroid cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, 200032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Light-Based probe aims to spot thyroid cancer faster
- Mapping how thyroid tumors spread and what surgery leaves behind
- Can a video keep thyroid cancer patients on track after surgery?
- Can doctors safely watch small thyroid cancers instead of removing them?
- Can heat replace the scalpel for small thyroid tumors?
- Thyroid surgery under the microscope: what 3,000 real operations reveal